vancomycin has been researched along with Exanthema in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 8 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, M; Adachi, T; Ichimura, C; Ishii, K; Ishiko, A; Yokota, M; Yoshida, K | 1 |
| Bhatt, S; Kothari, R; Mannu, A; Neema, S; Tripathy, DM; Vashisht, D; Vasudevan, B | 1 |
| Gacoń, E; Obal, M; Piechocki, K; Symonides, B | 1 |
| Bidell, MR; Molleti, RR; Tatara, AW | 1 |
| Guo, S; Wang, F; Wu, Y; Yin, W | 1 |
| Hou, N; Leng, B; Li, T; Yan, G | 1 |
| Awan, KS; Long, J; Yuan, K | 1 |
| Alomari, AK; Burton, K; Clark, D; Rahnama-Moghadam, S | 1 |
| Macri, A; Maxfield, L; Schlick, T; Thatcher, J | 1 |
| Salonen, BR; Vinnakota, S | 1 |
| K Heng, Y; Kuan, LY; Lim, YL; Pan, JY; Tan, CH; Tan, LS; Tee, SI | 1 |
| Sharma, U | 1 |
| Chamorro-Pareja, N; Gonzalez-Estrada, A; Patel, A; Youngberg, G | 1 |
| Alowami, S; Chin-Yee, B; El-Helou, P; Gangji, A; Lee, S; Lo, CK; Ribic, C; Wang, MK | 1 |
| Kaka, AS; Osawa, R | 1 |
| Agharazii, M; Desmeules, S; Riopel, J; Savard, S | 1 |
| Dufort, EM; Eberson, CP; Harwell, JI; Vinson, AE; Willis, MD | 1 |
| Dai, H; Gaedigk, A; James, LP; Jones, BL; Myers, AL; Neville, KA | 1 |
| Lynch, J; Moss, J; Renz, C; Thurn, J | 1 |
| Wilson, AP | 1 |
| Berner, Y; Levi, S; Shahar, A | 1 |
| Hoaglund, PA; McKinnon, PS; Mozaffari, E; Nolet, B; Tice, AD | 1 |
5 review(s) available for vancomycin and Exanthema
| Article | Year |
|---|---|
A rare case of infant eosinophilia induced by oral vancomycin: a case report and literature review.
Topics: Administration, Oral; Child; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Eosinophils; Exanthema; Humans; Infant; Vancomycin | 2023 |
A case of vancomycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome with failure to respond to cyclosporine treatment.
Topics: Cyclosporine; Drug Hypersensitivity Syndrome; Drug Resistance; Eosinophilia; Exanthema; Female; Forearm; Humans; Vancomycin | 2020 |
Crusted scabies in a renal transplant recipient treated with daily ivermectin: A case report and literature review.
Topics: Administration, Oral; Aged; Animals; Diagnosis, Differential; Exanthema; Humans; Immunosuppression Therapy; Ivermectin; Kidney Transplantation; Male; Recurrence; Sarcoptes scabiei; Scabies; Sepsis; Skin; Vancomycin | 2019 |
Maculopapular rash induced by oral vancomycin.
Topics: Administration, Oral; Aged; Enterocolitis, Pseudomembranous; Exanthema; Female; Humans; Vancomycin | 2008 |
Comparative safety of teicoplanin and vancomycin.
Topics: Animals; Anti-Bacterial Agents; Drug Hypersensitivity; Ear; Exanthema; Fever; Humans; Teicoplanin; Thrombocytopenia; Vancomycin | 1998 |
2 trial(s) available for vancomycin and Exanthema
| Article | Year |
|---|---|
Defining risk factors for red man syndrome in children and adults.
Topics: Adolescent; Amine Oxidase (Copper-Containing); Child; Child, Preschool; Erythema; Exanthema; Female; Flushing; Histamine; Hospitalization; Humans; Infant; Male; Polymorphism, Single Nucleotide; Pruritus; Risk Factors; Syndrome; Vancomycin; Young Adult | 2012 |
Histamine release during rapid vancomycin administration.
Topics: Anti-Bacterial Agents; Cimetidine; Diphenhydramine; Double-Blind Method; Drug Hypersensitivity; Exanthema; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Histamine Release; Humans; Hypotension; Infusions, Intravenous; Prospective Studies; Pruritus; Time Factors; Vancomycin | 1998 |
15 other study(ies) available for vancomycin and Exanthema
| Article | Year |
|---|---|
A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
Topics: Anti-Bacterial Agents; Exanthema; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Stevens-Johnson Syndrome; Vancomycin | 2021 |
Vancomycin Associated Purpuric Symmetrical Drug-Related Intertriginous and Flexural Exanthema: A Rare Association and an Uncommon Presentation.
Topics: Exanthema; Humans; Vancomycin | 2022 |
[Red man syndrome as a complication of vancomycin therapy].
Topics: Adult; Anti-Bacterial Agents; Erythema; Exanthema; Humans; Syndrome; Vancomycin; Young Adult | 2022 |
Fidaxomicin-Associated Hypersensitivity Reactions: Report of a Morbilliform Drug Eruption.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Eruptions; Exanthema; Female; Fidaxomicin; Humans; Hypersensitivity; Middle Aged; Pharmaceutical Preparations; Vancomycin | 2023 |
Vancomycin-induced reversible pancytopenia and rash in a 16-month-old boy with osteomyelitis: A case report
.
Topics: Anti-Bacterial Agents; Exanthema; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Pancytopenia; Staphylococcal Infections; Vancomycin | 2020 |
Vancomycin-induced drug rash with eosinophilia and systemic symptoms (DRESS).
Topics: Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Humans; Male; Middle Aged; Vancomycin | 2020 |
Vancomycin-associated drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: masquerading under the guise of sepsis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Diagnosis, Differential; Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Humans; Male; Methylprednisolone; Middle Aged; Pseudomonas aeruginosa; Sepsis; Vancomycin | 2017 |
Linear IgA bullous dermatosis: A rare manifestation of vancomycin hypersensitivity.
Topics: Aged, 80 and over; Allergens; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Drug Hypersensitivity; Exanthema; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Male; Prednisone; Skin; Vancomycin | 2018 |
A polymorphous rash of an uncommon blistering disease.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Betamethasone; Blister; Diagnosis, Differential; Exanthema; Glucocorticoids; Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Male; Piperacillin, Tazobactam Drug Combination; Prednisolone; Treatment Outcome; Vancomycin | 2018 |
Disseminated Lyme disease presenting as multiple non-target cellulitic-appearing skin lesions and oral pseudomembrane.
Topics: Anti-Bacterial Agents; Candidiasis, Oral; Doxycycline; Epstein-Barr Virus Infections; Exanthema; Fever; Headache; Humans; Lyme Disease; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2018 |
Case of drug reaction with eosinophilia and systemic symptoms secondary to vancomycin.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Daptomycin; Drug Hypersensitivity; Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Histamine Antagonists; Humans; Male; Treatment Outcome; Vancomycin | 2018 |
Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.
Topics: Acetamides; Acute Disease; Aged, 80 and over; Anti-Infective Agents; Eosinophilia; Exanthema; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Nephritis, Interstitial; Oxazolidinones; Prosthesis-Related Infections; Staphylococcal Infections; Syndrome; Vancomycin | 2009 |
Drug rash, eosinophilia, and systemic symptoms syndrome: Two pediatric cases demonstrating the range of severity in presentation--A case of vancomycin-induced drug hypersensitivity mimicking toxic shock syndrome and a milder case induced by minocycline.
Topics: Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Drug Hypersensitivity; Eosinophilia; Exanthema; Humans; Male; Minocycline; Severity of Illness Index; Shock, Septic; Syndrome; Vancomycin | 2010 |
Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Hypersensitivity; Drug Interactions; Exanthema; Female; Fever; Humans; Pancytopenia; Vancomycin | 2000 |
Cost perspectives for outpatient intravenous antimicrobial therapy.
Topics: Anti-Bacterial Agents; Cohort Studies; Data Collection; Exanthema; Fee-for-Service Plans; Fever; Home Infusion Therapy; Humans; Infusions, Intravenous; Infusions, Parenteral; Insurance, Health, Reimbursement; Kidney Diseases; Managed Care Programs; Medicaid; Medicare; Practice Patterns, Physicians'; Retrospective Studies; United States; Vancomycin | 2002 |